4.8 Article

New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries

Journal

NATURE GENETICS
Volume 51, Issue 3, Pages 481-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41588-018-0321-7

Keywords

-

Funding

  1. Wellcome Trust [WT202849/Z/16/Z]
  2. Medical Research Council (MRC) [MR/N011317/1]
  3. National Institute for Health Research (NIHR) Leicester Biomedical Research Centre
  4. NIHR Nottingham Biomedical Research Centre
  5. SpiroMeta consortium
  6. BBSRC [BB/F019394/1] Funding Source: UKRI
  7. ESRC [ES/S008349/1] Funding Source: UKRI
  8. MRC [G0700704, MC_UU_00007/10, MR/S003762/1, MC_UU_00017/1, MC_PC_12010, MC_PC_14135, MC_UU_12015/1, MR/N01104X/1, MR/N011317/1, 1805065, MC_UU_12026/2, G1000861, MR/N01104X/2, 1805084, MC_PC_13049, G1001799, MC_U137686851] Funding Source: UKRI

Ask authors/readers for more resources

Reduced lung function predicts mortality and is key to the diagnosis of chronic obstructive pulmonary disease (COPD). In a genome-wide association study in 400,102 individuals of European ancestry, we define 279 lung function signals, 139 of which are new. In combination, these variants strongly predict COPD in independent populations. Furthermore, the combined effect of these variants showed generalizability across smokers and never smokers, and across ancestral groups. We highlight biological pathways, known and potential drug targets for COPD and, in phenome-wide association studies, autoimmune-related and other pleiotropic effects of lung function-associated variants. This new genetic evidence has potential to improve future preventive and therapeutic strategies for COPD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available